Meet the People
that Power Progress

Our team is comprised of experienced leaders, drug developers, scientists, physicians, and operators who never accept “good enough” and are highly motivated to build medicines for life. Founded in 2022, Apogee leaders recognized that while existing drugs for certain inflammatory and immune diseases may work well, there is an opportunity to do better for patients – specifically, reducing the burden of frequent injections required in current treatment regimens by engineering and optimizing antibodies to be best in class, in order to improve the day-to-day lives of patients.